Microvascular Coronary Artery Disease Clinical Trial
Official title:
Additive Value of Physiology Coronary in Clinical Practice
The important evidence of coronary microcirculation for the management of patients with coronary artery disease is only increasing. Thus, in recent years, a number of studies have shown that the demonstration of coronary microvascular disease (CMVD) contributes to cardiovascular morbidity and mortality increases independently of epicardial damage. This has been shown in stable coronary artery disease with screening for CMVD when there is no significant epicardial involvement and allowing the implementation of an adapted treatment then reducing the symptoms and improving the quality of life of our patients. (1). The prognostic nature of CMVD has also been identified in stable disease after coronary angioplasty (2) but also in patients with infarcts reperfused by coronary angioplasty (3). The complete exploration of the epicardial and microvascular coronary vascularization is grouped under the name of the subspecialty: coronary physiology. Thus, an internationally recognized algorithm for exploring coronary physiology has been published (4). However, this algorithm is still little followed. The PRINCIPE registry aims to assess the prevalence of CMVD with the use of a standardized algorithm for exploring coronary physiology by coronary angiography in our center in current practice.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT04069234 -
Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention.
|
Phase 3 | |
| Recruiting |
NCT06080919 -
Plaque Modification And Impact On Microcirculatory Territory After Drug-Coated Balloon Percutaneous Coronary Intervention (PLAMI).
|
N/A | |
| Terminated |
NCT04614467 -
A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction
|
Phase 2 | |
| Terminated |
NCT03236311 -
A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI
|
Phase 2 | |
| Recruiting |
NCT04541797 -
Stress Cardiac Magnetic Resonance of Asymptomatic Type 2 Diabetics With Cardiovascular High Risk to Measure Empagliflozin Impact on Myocardial Blood Flow (CATCH-EM)
|
N/A | |
| Recruiting |
NCT04598308 -
EUROpean Coronary microCirculatory Resistance and Absolute Flow Trial
|
||
| Active, not recruiting |
NCT05197361 -
Microvascular Coronary Resistance and Absolute Coronary FLOW in Patients With Percutaneous Intervention of a Chronic Total Occlusion
|
||
| Recruiting |
NCT04827498 -
Myocardial Ischemia Without Obstructive Coronary Stenoses
|
||
| Suspended |
NCT05756088 -
Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury by Donor Derived Cell Free DNA
|
||
| Recruiting |
NCT06118450 -
Clinical Trial for Evaluating the Effectiveness and Safety of Online caIMR in STEMI Patients
|
||
| Recruiting |
NCT03217227 -
Evaluating Myocardial Ischemia in Chest Pain Using Exercise CMR
|
||
| Completed |
NCT03462017 -
Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus
|
Phase 1 | |
| Not yet recruiting |
NCT06269874 -
Study Comparing Two Administration Pathways for Adenosine During Microvascular Function Assessment
|
N/A | |
| Not yet recruiting |
NCT06217120 -
Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
|
Phase 2/Phase 3 | |
| Recruiting |
NCT06316661 -
CMR Assessment of Cardiac Microvascular Dysfunction in Patients With HFpEF
|
||
| Recruiting |
NCT04131075 -
The Cerebral-Coronary Connection (C3) Study
|
||
| Completed |
NCT04485234 -
Inclusive Invasive Physiological Assessment in Angina Syndromes Registry
|
||
| Completed |
NCT05471739 -
Simultaneous Assessment of Coronary Microvascular Dysfunction and Ischemia With Non-obstructed Coronary Arteries With Intracoronary Electrocardiogram and Intracoronary Doppler
|
||
| Completed |
NCT05406297 -
Impact of TMAO Serum Levels on Hyperemic IMR in STEMI Patients
|
||
| Not yet recruiting |
NCT06069401 -
The MASTER-PACT Study
|